PMID: 9435250Jan 22, 1998Paper

Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity

Proceedings of the National Academy of Sciences of the United States of America
P S ChowdhuryI Pastan

Abstract

Mesothelin is a differentiation antigen present on the surface of ovarian cancers, mesotheliomas, and several other types of human cancers. Because among normal tissues, mesothelin is present only on mesothelial cells, it represents a good target for antibody-mediated delivery of cytotoxic agents. In the present study mice were immunized with an eukaryotic expression vector coding for mesothelin. When high serum antibody titers were obtained, a phage display library was made from the splenic mRNA of these mice. After three rounds of panning on recombinant mesothelin, a single-chain Fv (scFv)-displaying phage was selected that bound specifically to recombinant mesothelin and mesothelin-positive cells. The scFv was used to construct an immunotoxin by genetically fusing it with a truncated mutant of Pseudomonas exotoxin A. The purified immunotoxin binds mesothelin with high affinity (Kd 11 nm), is stable for over 40 hr at 37 degrees C and is very cytotoxic to cells expressing mesothelin. It also produces regressions of tumors expressing mesothelin. This combination of selective cytotoxicity, high activity, and stability makes the immunotoxin a good candidate for development as a therapeutic agent. This work also shows that DNA imm...Continue Reading

References

Mar 1, 1992·The American Journal of Surgical Pathology·K ChangM C Willingham
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·U BrinkmannI Pastan
Oct 21, 1993·The New England Journal of Medicine·O W PressB Porter
May 11, 1995·Journal of Immunological Methods·U BrinkmannI Pastan
Dec 2, 1994·Journal of Immunological Methods·J J DonnellyM A Liu
May 27, 1994·Biochimica Et Biophysica Acta·U Brinkmann, I Pastan
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·K Chang, I Pastan
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·E RazD A Carson
Jun 1, 1996·Journal of Medical Primatology·J D BoyerD B Weiner
Jan 1, 1997·Molecular Immunology·P S ChowdhuryI Pastan
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A OsterborgH Mellstedt

❮ Previous
Next ❯

Citations

Jan 10, 2008·Annals of Biomedical Engineering·Kevin C ChenByungkook Lee
Nov 11, 2003·Journal of Molecular Biology·Amita GuptaVijay K Chaudhary
Feb 28, 2001·Journal of Immunological Methods·P S ChowdhuryI Pastan
Nov 25, 2003·Lancet·Bruce W S RobinsonIngegerd Hellstrom
Dec 1, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Evripidis LanitisDaniel J Powell
Nov 28, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tae Heung KangChien-Fu Hung
Jun 24, 2006·Nature Reviews. Cancer·Ira PastanRobert J Kreitman
May 16, 2012·Protein Engineering, Design & Selection : PEDS·Eve E WeatherillDavid P Humphreys
Aug 6, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Raffit HassanMark C Willingham
Nov 10, 2001·Annual Review of Biomedical Engineering·J Maynard, G Georgiou
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Junko YokokawaKwong Y Tsang
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J KreitmanIra Pastan
Nov 3, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raffit HassanDaniel Laheru
Apr 28, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Miriam E MossobaDaniel H Fowler
Feb 22, 2012·Molecular Cancer Therapeutics·Ronan J KellyRaffit Hassan
Jun 28, 2008·American Journal of Respiratory and Critical Care Medicine·Eun-Kee ParkAnthony R Johnson
Oct 10, 2006·The AAPS Journal·Robert J Kreitman
Sep 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Frederico Aires da SilvaJoao Goncalves
Sep 29, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Mitchell Ho
May 8, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·Q Lou, I Pastan
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·N SchollerI Hellström
Jun 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Avital LevYoram Reiter
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·U BrinkmannI Pastan
Oct 19, 2011·Biotechnology Research International·Shukra M AavulaSrinivasan Alwar Villuppanoor
Dec 1, 2001·Expert Opinion on Biological Therapy·U BrinkmannP Hafkemeyer
Jul 5, 2005·Expert Opinion on Investigational Drugs·R J Kreitman
Nov 22, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Ripen MisriUrs O Häfeli
Apr 23, 2011·Drug Discovery Today·Swati ChoudharyRama S Verma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.